Receive 30% off all Monoclonal IHC antibodies with code "MONO-IHC-30"! Offer valid for US customers and available internationally through distributors.
Blog Menu
Bioss to Attend Immunology 2019 in San Diego

Bioss to Attend Immunology 2019 in San Diego

Bioss Antibodies is excited to be attending IMMUNOLOGY 2019, the 103rd Annual Meeting of the American Association of Immunologists, in San Diego from May 9 - 13. Our team will be in the exhibit hall Friday, Saturday, and Sunday at Booth 538.

Read more

Applying Nanolipidgels, Researchers Probe New Kidney Disease Target CaMK4

Applying Nanolipidgels, Researchers Probe New Kidney Disease Target CaMK4

A study in The Journal of Clinical Investigation by George C. Tskokos and his team at Beth Israel Deaconess Medical Center demonstrates that Calcium/Calmodulin-Dependent Protein Kinase IV (CaMK4) is overexpressed in injured podocytes. This makes CaMK4 a promising therapeutic target for treatment of chronic kidney disease.

Read more

An Unexpected Candidate in the Search for Liver Cancer Therapies

An Unexpected Candidate in the Search for Liver Cancer Therapies

pIC, or polyinosinic-polycytidylic acid, is a synthetic double-stranded RNA molecule that affects the innate immune system — the cellular defense system that allows an organism to recognize and eliminate threats to the body. In this study, the authors suggest that pIC reprograms immune cells such as macrophages and natural killer cells, which subsequently prevents tumors from forming in their animal models.

Read more